Skip to main content

PRIMECAP MANAGEMENT CO/CA/

Position in ZNTL — Zentalis Pharmaceuticals, Inc.

CIK 763212 PASADENA, CA

Position in ZNTL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,643,487
+$2,403,125 QoQ
Shares Held
957,420
0.0% QoQ
Ownership
1.34%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 114 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in ZNTL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRIMECAP MANAGEMENT CO/CA/ holds $3,557,107,452 across 15 Biotechnology names. ZNTL ranks #14 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ZNTL

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,643,487 957,420
2026-03-31 $2,240,362 957,420
2025-12-31 $1,292,517 957,420
2025-09-30 $1,453,556 962,620
2025-06-30 $1,192,039 1,027,620
2025-03-31 $2,010,745 1,264,620
2024-12-31 $4,607,508 1,520,630
2024-09-30 $5,512,750 1,498,030
2024-06-30 $5,040,270 1,232,340
2024-03-31 $18,354,253 1,164,610
2023-12-31 $15,503,752 1,023,350
2023-09-30 $20,737,025 1,033,750
2023-06-30 $31,345,541 1,111,150
2023-03-31 $19,417,424 1,128,920
2022-12-31 $22,761,623 1,130,170
2022-09-30 $25,552,302 1,179,700
2022-06-30 $33,495,200 1,192,000
2022-03-31 $55,764,342 1,208,590
2021-12-31 $105,380,978 1,253,640
2021-09-30 $89,005,716 1,335,620
2021-06-30 $71,746,052 1,348,610
2021-03-31 $57,944,307 1,335,430
2020-12-31 $71,245,578 1,371,690
2020-09-30 $45,202,097 1,382,750
2020-06-30 $31,690,799 659,950